WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 85'5501 Infant (under 12 months) mortality rate: 62
GDP / capita (US$): 131'7581 Child (under 5 years) mortality rate: 72

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 2'169  2'051  1'911  1'750  1'564  594  477  224 
Births 23  22  21  20  19  12  11 
Surviving infants 23  22  21  20  18  12  10 
Pop. less than 5 years 109  99  91  86  81  55  52  34 
Pop. less than 15 years 295  279  261  240  226  154  135  75 
Female 15-49 years 325  308  290  270  250  119  82  41 

Number of reported case

(Click for retrospective incidence data for Qatar)
Diphtheria
Japanese encephalitis
Measles 73  160  101  295  112  46  314  392 
Mumps 289  382  368  151  407  65 
Pertussis 11  18  219 
Polio*
Rubella 58  20  16  23  14  16 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Qatar)
Vaccine year result method % card seen                                                
BCG 1997  96  FHS   89  99  97  97  99  98  100  97 
DTP1 1997  95  FHS   89  100  94  94  98  98  92 
DTP3 1997  91  FHS   89  100  92  93  97  99  80  82  61 
HepB_BD          96  95  96  99  94  99 
HepB3 1997  85  FHS   89  100  92  93  97  99  89 
Hib3          100  92  93  97  99  80 
JapEnc         
MCV 1997  90  FHS   89  100  97  99*  99  100  91  79  26 
MCV2          100  99*  99*  98  99 
PCV1          100  99*  99*  99  100 
PCV3          100  92  98  97  99 
Pol3 1997  88  FHS   89  100  92  93  98  98  91  82  61 
Rota1          97  90  98  55  59 
Rota_last          87  80  83  40  41 
Rubella1          100  97  99  100 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Qatar)
BCG 98  97  97  99  98  99  97 
DTP1 99  94  94  98  99  92  94  82 
DTP3 99  92  93  97  99  80  82  61 
HepB3 99  92  93  97  99  89 
HepB_BD 96  95  96  99  94  99 
Hib3 99  92  93  97  99  80 
MCV 99  97  98  99  99  91  79  26 
MCV2 99  99  99  98  99 
PCV3 99  92  98  97  99 
Pol3 99  92  93  98  98  91  82  61 
Rota_last 87  80  83  40  41 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaP 4-6 years; Yes
DTaPHib 15 months; Yes
DTaPHibHepIPV 2 months; Yes
DTwPHibHepB 4, 6 months; Yes
HepA 12, 18 months; Yes
HepB birth; Yes
MMR 12, 18 months; Yes
MenACWY Yes High risk only
OPV 4, 6, 18 months; 4-6 years; Yes
Pneumo_conj 2, 4, 6, 15 months; Yes
Pneumo_ps 65 years; Yes High risk
Rotavirus 2, 4 months: Yes
Tdap 11-12 years; Yes
Varicella 12 months; 4-6 years Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes    Yes 
What years does the MYP cover? number 2011-2016  2011-2016  2011-2016  2011-2016  2010-2012    2008-2009 
Nº of districts with microplans that include activities to raise immunization coverage number             35 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number NA  NA       
Nº districts with DTP3 coverage >=80% number    
% of districts with DTP3 coverage >=80% From 0 to 100%         100   
Nº districts with measles (MCV1) coverage >=95% number          
% of districts with MCV1 coverage >=95% From 0 to 100%         100     

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No  Yes    Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100      95   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.